Please use this identifier to cite or link to this item:

Title: Diagnostic markers for glioblastoma
Issue Date: 2011
Publisher: F. Hernández y J.F. Madrid. Murcia: Universidad de Murcia, Departamento de Biología Celular e Histología.
ISSN: 1699-5848
Related subjects: 616 - Patología. Medicina clínica. Oncología
Keywords: Glioblastoma
Abstract: Glioblastoma (GBM) is the most malignant form of cerebral gliomas, and despite distinct progress in surgical resection, radiation and chemotherapy, the prognosis of patients with GBM is still very poor. In the past decades knowledge of genomics and proteomics and of diagnostic, prognostic, predictive and pharmakodynamic markers measured in cerebrospinal-fluid (CSF), serum, or tumor tissue biomarkers has improved. This review briefly compiles our concepts on diagnostic markers for GBM, focusing on the latest developments.
Primary author: Jung, C.S.
Unterberg, A.W.
Hartmann, C.
Published in: Histology and histopathology, Vol. 26, nº10 (2011)
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 15
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.26,nº10 (2011)

Files in This Item:
File Description SizeFormat 
Jung-26-1327-1341-2011.pdf581,86 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons